Stock GANGAPHARM6 GANGA PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Ganga Pharmaceuticals Limited

Equities

GANGAPHARM6

INE615T01017

Market Closed - Bombay S.E.
Other stock markets
 03:30:55 24/06/2024 pm IST 		5-day change 1st Jan Change
24.67 INR -.--% Intraday chart for Ganga Pharmaceuticals Limited -.--% -13.41%
16/05 Ganga Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
19/01 Ganga Pharmaceuticals Limited announced that it has received INR 17.0625 million in funding from Lenus Finvest Pvt Ltd, Plutus Capital Management Llp CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ganga Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Ganga Pharmaceuticals Limited announced that it has received INR 17.0625 million in funding from Lenus Finvest Pvt Ltd, Plutus Capital Management Llp
CI
Ganga Pharmaceuticals Limited announced that it expects to receive INR 21 million in funding from Lenus Finvest Pvt Ltd, Plutus Capital Management Llp
CI
Ganga Pharmaceuticals Board to Consider Issuing Equity, Convertible Warrants to Raise Funds
MT
Ganga Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2023
CI
Ganga Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Ganga Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2022
CI
Ganga Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2022
CI
Ganga Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2021
CI
Ganga Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2020
CI
Ganga Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020
CI
Ganga Pharmaceuticals Limited Announces Management Changes
CI
Ganga Pharmaceuticals Limited Announces the Appointment and Re-Designation of Sanjay Kulkarni as Executive Director
CI
Ganga Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2019
CI
874,550 equity shares of Ganga Pharmaceuticals Limited are subject to a Lock-Up Agreement Ending on 23-FEB-2019.
CI
Ganga Pharmaceuticals Limited Reports Unaudited Standalone Earnings Results for the Half Year Ended September 30, 2018
CI
Ganga Pharmaceuticals Limited Appoints Anagh B. Sharma as Chief Financial Officer
CI
Ganga Pharmaceuticals Limited Announces Resignation of Ganesh Jyothimani Paradeshi, Chief Financial Officer
CI
Ganga Pharmaceuticals Limited Announces Audited Standalone Earnings Results for the Half Year and Full Year Ended March 31, 2018
CI
Ganga Pharmaceuticals Limited Reports Unaudited Standalone Earnings Results for the Half Year Ended September 30, 2017
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GANGAPHARM6 Stock
  4. News Ganga Pharmaceuticals Limited